Venture capital investors are shifting focus from digital pharmacies like PharmEasy to niche healthtech startups, backing firms in AI diagnostics, stem cell therapy, and medical devices.
​Venture capital investors are shifting focus from digital pharmacies like PharmEasy to niche healthtech startups, backing firms in AI diagnostics, stem cell therapy, and medical devices. by Soban News (international And National News)
